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Abstract
In many jurisdictions, organ allocation is done on the basis of the health status
of the patient, either explicitly or implicitly. This paper presents a self-promoting
priority queueing model for patient waiting times which takes into account changes in
health status over time. In this model, most patients arrive as “regular” customers
to the queue, but as the health of a patient degrades, their status is promoted to
“priority” to reflect the increased urgency of the transplant. We model the queueing
system as a level-dependent quasi-birth-and-death process, and the steady-state joint
queue length distribution as well as the marginal delay distributions for each queue
are computed via the use of matrix analytic techniques. The model is calibrated using
liver transplantation wait-list data, provided by a regional health centre in Canada,
that tracked approximately 1,100 patients over nearly 13 years. Blood-type specific
models are fit and performance measures, such as the mean and distribution of the
time until transplant, are obtained and compared to empirical estimates calculated
using the raw data.
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1 Introduction
Solid organ transplantation is a therapy that is used widely around the world, to treat
patients whose life expectancy can be meaningfully increased by the replacement of one
or more organs that are failing. During the half century or so that transplantation has
been a viable option in the treatment of patients with a failing organ, wait lists have been
established for patients awaiting a suitable organ. In many jurisdictions, these wait lists
have operated under a variety of modifications to the first come, first transplanted (FCFT)
discipline, to account for the patient’s health status. In recent years, however, patterns
have developed which specifies this modification in a formal way. For example, Wiesner et
al. [27] developed the “Model for End-stage Liver Disease (MELD) Score” as a means for
ranking patients periodically so that those whose health status was degrading more quickly
would gain priority access to a deceased-donor liver. The resulting service discipline used
for the liver transplant wait lists does not fit into the realm of existing FCFT or priority
queueing models, since a wait-listed patient’s priority depends upon their health status,
which in turn is influenced by the amount of time they have spent waiting.
Delays while patients await transplantation are frequently lengthy, often on the order
of years, as has been observed by numerous authors for multiple organ types in a variety of
jurisdictions. A sample of these studies follows which gives an indication of the variety of
contexts in which this problem has been recognized: kidneys in Germany (Glander et al.
[7] and Liefeldt et al. [18]), hearts in the UK (Hussey et al. [9]), kidneys in the US (Zenios
et al. [29]), and livers in the US (Barone et al. [2]) and in Canada (Stanford et al. [21]).
Despite this fact, the use of analytical queueing models specifically to address transplant
waiting times on the wait lists has been somewhat limited. The goal of this paper is to
present a full analysis and application of a queueing model which we develop for liver-
transplant patients of each ABO blood type that reflects the sickest patient first aspect
and allows for abandonments. We derive the steady-state queue length and marginal delay
distributions. We derive estimators for the parameters, and we calibrate and assess the fit
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of the model using real wait-list data. Our work demonstrates how queueing theory can
produce a model which can be used to provide a reasonable indication of key performance
measures, such as the likelihood of successful transplantation (either prior to or after a
degradation in health status), and the likelihood of abandonment or of death while waiting.
Zenios [28] appears to have been the first to present a queueing model for transplant
waiting times. This queueing model was used in turn by Zenios et al. [29] in their study
of kidney transplant wait lists in the US. The kidney allocation problem was revisited by
Su and Zenios [23], from the perspective of customer choice. Further details on the specific
assumptions of these papers follows later on in this section.
Stanford et al. [21] combined a statistical analysis of patient placements and deceased-
donor organ availability with a section presenting simple queueing models to assess the
consequences of three strategies to try to close a well-documented gap between the demand
for donor livers and their availability in Canada. The statistical analysis revealed that in
most of the Canadian regional liver transplant wait lists between 2000 and 2004, deceased-
donor organ availability was well-approximated by a Poisson process. At the same time,
patient placement differed significantly from a Poisson process in all cases. Working with a
GI/M/1 model, the authors investigated the relative merits of increased donor card signing,
greater reliance upon living donors, and a lottery system to allocate the limited number of
organs available.
Recently, Stanford et al. [22] used a queueing model to respond to a recent development
in addressing the so-called “Blood Type O Problem” (see [7]), in which too many type O
organs are cross-transplanted to compatible blood groups, causing notably longer waits for
blood type O recipients due to the reduced supply of O organs. Glander et al. [7] noted
that this frequently has led to situations in which blood type O recipients experience worse
health outcomes in terms of statistically-significant higher mortality rates during their
longer waiting times. The authors also observed that there are “poorer graft outcomes”
for type O recipients as a result. The analysis in [7] and [18] led to a change in the kidney
transplant policy employed by the the Eurotransplant zone effective late 2011, insisting
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upon ABO-identical transplantation. Aware of this development, Stanford et al. [22]
developed a construct called the “Array of Idealized Transplant Queues (AITQ)”, which
was used to show that an ABO-identical transplant policy would be incapable in the long
run of delivering comparable waiting times for all blood groups in the Canadian context
(and by implication, any jurisdiction with a close match to the Canadian blood mix of
46% O, 42% A, 9% B, and 3% AB – see [5]). While ABO-identical transplantation would
indeed resolve the blood type O problem, it would replace it with an even worse problem
for patients of blood types B and AB, due to the relative rarity of these organs in the
population at large. The analysis in [22] established that ABO-identical transplantation
would lead to delays typically five (respectively, fifteen) times longer for blood group B
(respectively, AB) patients in Canada and other countries with a close mix of blood types
in the population.
We note as an aside that there are also studies involving simulations from queueing
models which have been used to numerically examine the behaviour of kidney transplant
wait lists; we note in particular the work of Abellán et al. [1] in this regard. However, we
will not be considering simulation models in the remainder of this paper.
The goal of Stanford et al. [22] was to establish the long-run inability of an ABO-
identical transplantation policy to deliver comparable waiting times for all blood groups.
The question being addressed was the long-run system waiting time experience of the four
blood groups, rather than individual patient experience. As such, its purpose was to address
transplant policy, whereas the present paper has as its goal the development of a queueing
model to assess patient waiting times on the wait lists. In our view, all of the previous
models have either ignored or inadequately described one key aspect of deceased-donor
transplant wait lists or another, as we now review. The interested reader is advised to
also review the text in [22] where the distinguishing factors which arise in transplant queue
settings are discussed at some length.
The first such factor is queue abandonment: the tendency for patients to leave the wait
list due to death, a degradation in health status, personal reasons, or even in some cases,
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improvement in patient health to the point where transplantation is no longer the preferred
therapy. Stanford et al. [22] commented upon, but did not incorporate a mechanism for
abandonments, as it affects all blood groups, and as such had secondary impact upon the
blood type issue they addressed. Zenios [28] did account for abandonments, but did so at an
exponential rate independent of the queue length, as opposed to a rate that is proportional
to the number on the wait lists, which is a feature of the model we present herein.
The second factor is the service discipline: the fact that many transplant queues do
not at present typically follow a FCFT discipline, but instead treat wait-listed patients
who experience a degradation in health status on a priority basis (so long as they are
still candidates for transplantation). None of the foregoing transplant papers reflected
this priority aspect, which we attempt to do by invoking the idea of patients who “self
promote” from regular status to priority status at an exponential rate, while waiting. The
“self-promoting” literature is fairly extensive, comprising Krishnamoorthy and Narayanan
[11], Wang [26], Gómez-Corral et al. [8], and Krishnamoorthy et al. [12, 13, 14, 15]. In
telecommunication systems, the idea of promoting packets with low priority status to the
high priority queue is referred to as “priority jumps” and has been studied in the recent
past as well (e.g., see Maertens et al. [19], and references therein).
It is our view that a third factor, not adequately discussed in the queueing models apart
from [22], is the fundamental role that patient and donor ABO status plays in determin-
ing individual patient waiting time experience. We feel it needs to be explicitly factored
into the wait time modelling, as we do, for most jurisdictions in the world. A particular
exception might be the US case, where the transplant system comprises a large network of
centres arranged nationally, regionally, and locally, in which organs are procured under the
Organ Procurement and Transportation Network (OPTN) and allocated under the rules
of the United Network of Organ Sharing (UNOS). The UNOS rules include aspects which
indicate under what circumstance compatible transplantation is allowed or not alongside
the decisions about where the organ will be allocated. The complicated nature of these
interactions of the various levels tends to obscure the role that blood type plays in the
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US environment. In most jurisdictions that we are aware of, such as Canada and the
Eurotransplant zone, organs are routinely allocated on an ABO-identical basis. Rules for
access to ABO-compatible organs on the basis of urgent need vary depending on the organ
to be transplanted and the jurisdiction. The numerical examples we present, which con-
siders the experience of one particular Canadian liver transplantation centre, reflects the
fact that there are interlinked wait lists. The principal way that this will manifest itself
herein is that, in the data used for model calibration, we will aggregate both ABO-identical
and ABO-compatible organs that were transplanted into patients of each of the four blood
types.
We remark that the model presented herein is one for deceased-donor transplant wait
lists. It is true that transplanted kidneys and livers can come from deceased donors or
living ones. Widely known in the case of kidneys, this is also true for the liver, one lobe
of which can be grafted into the recipient, while the donor retains the other. While living-
donor transplantation could be viewed as another type of abandonment from the queue,
such abandonments are planned, not random. We do not directly address the issue of such
planned transplants in our model.
In summary, the pursuit of a suitable analytical queueing model to infer a likely waiting
time for patients awaiting a deceased-donor organ transplantation is both timely and war-
ranted, given the importance of the problem. The present paper is the first we are aware of
to address the sickest patient first aspect, and to adequately address the question of aban-
donments. Such a model would be useful for decision makers to explore qualitatively the
impact of various changes that could arise on the waiting times experienced by individual
patients, in advance of such changes taking place. An example of potential decision mak-
ers, but by far not the only ones, would be teams of medical professionals and performance
modellers interested in exploring the impact of the types of changes we list below.
Examples of policy changes that would likely impact waiting time include such aspects
as: (i) the merging of formerly separate wait lists, (ii) changes in policies regarding ABO-
identical versus ABO-compatible cross-transplantation, or the controlled policies in this
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regard in light of Stanford et al. [22], (iii) a decrease in deceased donor organ rates due to
improvements in accident prevention, and (iv) in the case of kidneys, a change in demand
for deceased donor organs (and possibly the blood mix of the remaining recipients on the
list) due to the increased use of “transplant chains” involving living donors. Other like
examples can be thought of readily.
The present work presents a model for patients of each ABO blood type, reflecting the
factors stated above, that can be used to provide a reasonable indication of the relative
likelihood of the possible outcomes that individual patients can experience: successful trans-
plantation prior to perceived health degradation, successful transplantation as a priority
patient due to health degradation, the likelihood of abandonment or death while waiting,
etc., as well as estimates of the time spent waiting.
The rest of the paper is organized as follows. In the next section, the details of our
queueing model are specified. In Section 3, the underlying steady-state distribution for
the model is obtained. Delay distributions for high-priority (HP) and low-priority (LP)
wait-listed patients are investigated in the subsequent two sections. Section 6 develops
estimators for the model parameters using a maximum-likelihood-based approach under a
competing risks framework. Section 7 presents the results from an initial case study of
real liver transplantation wait-list data: blood-type specific models are fit to this data and
model-based performance measures are compared to qualitatively assess goodness of fit.
The paper ends with some observations and concluding remarks in Section 8.
2 Description of the Queueing Model
Consider the queueing model depicted in Figure 1 in which a single server provides service
to two classes (class 1 and class 2) of transplant requests, each having its own respective
line. Wait-listed patients are served on a FCFT basis within their own line. As organ
availability is always the limiting factor, the service time constitutes the interval from
when a wait-listed patient reaches the head of their queue until an organ becomes available
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to him/her. Furthermore, class 1 has preemptive priority over class 2, implying that a
class-2 patient in service (i.e., next in line to receive an organ) would be preempted by an
arriving class-1 patient to the system. Let m < ∞ and n < ∞ be the buffer sizes of the
LP and HP queues, respectively.
Figure 1: Proposed Queueing Model
We define λ1 and λ2 to be the respective (independent) Poisson arrival rates of HP and
LP patients to the system. We allow for different service rates for HP and LP patients, both
for reasons of generality, and to reflect situations in which patients with an urgent need for
transplant have wider access to deceased-donor organs. Let µ1 and µ2 be the (individual)
independent and exponentially distributed HP and LP service rates, respectively.
We distinguish between the reneging/abandonment behaviours of the two patient
classes. At the class-1 level, reneging patients leave the system at rate α1 and are unrecov-
erable (reflecting deaths and “coming off-list”). In contrast, at the class-2 level, patients
renege at rate α2, and either leave the system with probability q (for patients who die or
come off-list) or are immediately promoted to the end of the HP queue with probability
p = 1− q (reflecting degraded health status still suitable for transplantation). Once in the
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HP queue, further reneging for such promoted patients occurs at the class-1 rate α1. Note
that a patient who reaches the service stage is still subject to potential reneging (since
service constitutes waiting for an organ to become available).
The concept of self-generation of priorities was proposed by Krishnamoorthy and
Narayanan [11] and subsequently analyzed in a series of papers by Wang [26], Gómez-
Corral et al. [8], and Krishnamoorthy et al. [12, 13, 14, 15], most of which essentially
concern a model where regular customers in a multi-server, single class queue would “self-
promote” at a constant rate while waiting, independently of other customers in the queue.
A self-promoted customer would displace any non-priority item in service. For the foregoing
models, in the event that no regular customers were found in service, the promoted cus-
tomer leaves the queue to obtain urgent service elsewhere. In contrast, our self-promoted
customers join the HP queue and only immediately depart the system if no waiting space
is available in the HP queue.
In this paper, we determine the following main performance measures associated with
our queueing model:
(i) The steady-state joint queue length probability πi,j = Pr(XL = i,XH = j) for the
number of HP patients, XH , and LP patients, XL, present in the system, as well as










The joint queue length distribution {πi,j ; i = 0, 1, . . . ,m, j = 0, 1, . . . , n} is obtained
in Section 3.
(ii) The cumulative distribution function (CDF) and moments related to the stationary
waiting time W ∗H of an originally-arriving HP patient who successfully completes
service prior to reneging, obtained in Section 4.
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(iii) The CDF and moments related to the stationary waiting time W ∗L,1 of an arriving
LP patient who successfully completes service within the LP queue prior to reneging,
obtained in Section 5.
(iv) The CDF and moments related to the stationary waiting time W ∗L,2 of a promoted
LP patient from the point of transfer to the HP queue until that patient successfully
completes service prior to reneging, obtained also in Section 5.
(v) The probabilities HPRenege, LPRenege, and PromLPRenege representing the var-
ious likelihoods that a patient reneges prior to receipt of an organ. Specifically,
HPRenege is the probability that a patient who arrives as HP will renege, LPRenege
is the reneging probability for a LP patient, and PromLPRenege is the reneging prob-
ability for a HP patient who initially arrived as LP. These probabilities are determined
in Sections 4 and 5.
3 Determination of the Steady-state Probabilities
Our first objective is to determine the steady-state joint probabilities {πi,j ; i =
0, 1, . . . ,m, j = 0, 1, . . . , n}, where πi,j = Pr(XL = i,XH = j). We say that the pro-
cess is “at level i” whenever XL = i. For k ≥ 0, we define the kth steady-state probability
row vector (of dimension n + 1) to be πk = (πk,0, πk,1, . . . , πk,n). Let π = (π0, π1, . . . , πm)
be the concatenated steady-state probability row vector having a total of m+ 1 levels. To
determine π, we need to solve 0̃ = πQ where Q is the infinitesimal generator of the process
and 0̃ = (0, 0, . . . , 0) is the concatenated row vector (having a total of m+1 levels) in which
0 denotes a 1× (n+ 1) row vector of zeros.
With XL serving as the level of the process (and XH as the sub-level), we note that
Q is block-structured with blocks Qi,j (of size n + 1) containing all transitions where XL
changes from i to j. Due to the presence of reneging in the model and the fact that XL
can only change by ±1, we end up with a level-dependent quasi-birth-and-death (QBD)
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process having infinitesimal generator of the form
Q =

0 1 2 · · · m− 2 m− 1 m
0 Q0,0 Q0,1 0 · · · 0 0 0
1 Q1,0 Q1,1 Q1,2
. . . 0 0 0
2 0 Q2,1 Q2,2









m− 2 0 0 0 · · · Qm−2,m−2 Qm−2,m−1 0
m− 1 0 0 0 · · · Qm−1,m−2 Qm−1,m−1 Qm−1,m
m 0 0 0 · · · 0 Qm,m−1 Qm,m

. (1)
In (1) above, 0 denotes an appropriately dimensioned square matrix of zeros (which, in this
case, is of dimension n+1). The overall dimension of Q is (m+1)(n+1)× (m+1)(n+1).
Note that Q0,1 = Q1,2 = · · · = Qm−1,m = λ2In+1 where Ik, in general, denotes the k×k
identity matrix. Moreover, it readily follows that
Qi,i−1 =

0 1 2 · · · n− 1 n
0 µ2+iqα2 ipα2 0 · · · 0 0
1 0 iqα2 ipα2
. . . 0 0
2 0 0 iqα2








n− 1 0 0 0 · · · iqα2 ipα2
n 0 0 0 · · · 0 iα2

, i = 1, 2, . . . ,m.
For notational convenience, we define λ = λ1 + λ2, βi = µ1 + iα1, and γi = µ2 + iα2. Also,
let ek be a 1× k row vector with 1 as the first entry and zeros everywhere else. Based on
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this notation, the diagonal components of Q can be expressed as
Q0,0 =

0 1 2 · · · n− 1 n
0 −λ λ1 0 · · · 0 0
1 β1 −(λ+ β1) λ1
. . . 0 0
2 0 β2 −(λ+ β2)








n− 1 0 0 0 · · · −(λ+ βn−1) λ1





0 1 2 · · · n− 1 n
0 −(λ1+γm) λ1 0 · · · 0 0
1 β1 −(λ1+β1+mα2) λ1
. . . 0 0
2 0 β2 −(λ1+β2+mα2)








n− 1 0 0 0 · · · −(λ1+βn−1+mα2) λ1






0 1 2 · · · n− 1 n
0 −(λ+ γi) λ1 0 · · · 0 0
1 β1 −(λ+ β1 + iα2) λ1
. . . 0 0
2 0 β2 −(λ+ β2 + iα2)








n− 1 0 0 0 · · · −(λ+ βn−1 + iα2) λ1
n 0 0 0 · · · βn −(λ2 + βn + iα2)

for i = 1, 2, . . . ,m− 1.
Level-dependent QBDs have been well-studied in the literature (e.g., see Bright and
Taylor [4]), and it is possible to adapt a computational procedure proposed by Gaver et
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al. [6] to calculate the steady-state probabilities associated with our model, which we now
summarize below. The equilibrium equations in block form are as follows:
0 = π0Q0,0 + π1Q1,0, (2)
0 = λ2πi−1 + πiQi,i + πi+1Qi+1,i, i = 1, 2, . . . ,m− 1, (3)
0 = λ2πm−1 + πmQm,m. (4)




Rj , i = 1, 2, . . . ,m, (5)
where the set of matrices {Rj}mj=1 satisfy the recursive relation
Rj = −λ2(Qj,j +Rj+1Qj+1,j)−1, j = 1, 2, . . . ,m− 1,
with
Rm = −λ2Q−1m,m.
Defining R0 = Q0,0 +R1Q1,0, (2) becomes
π0R0 = 0. (6)







n+1 + · · ·+ π0R1R2 · · ·Rm1′n+1 = 1, (7)
where 1′k, in general, denotes a k× 1 column vector of ones. Factoring out π0 from (7) and








(6) and (7) give rise to the following system of linear equations which must be solved to
determine π0, namely:
π0[R0, u
′] = (0, 1). (8)
In (8) above, [R0, u
′] and (0, 1) represent concatenated matrices of sizes (n + 1) × (n + 2)
and 1× (n+ 2), respectively. Once π0 is determined, we obtain πi, i ≥ 1, via (5).
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4 Delay Distributions for HP Transplant Requests
We focus initially on the stationary distribution of a random variable WH , representing the
duration of time from the arrival of an external HP patient to the system until this patient
successfully completes service. We refer to WH as the “nominal” HP patient delay, as we
implicitly assume that there is room in the HP queue for the arriving patient to enter the
system, and that the arriving HP patient is not subject to reneging. (Later on, we will
incorporate the reneging behaviour of this patient in our analysis.)
Define the following conditional steady-state probabilities, given that a random HP




, i = 0, 1, . . . ,m, j = 0, 1, . . . , n− 1.
Let FH(ω), ω ≥ 0, denote the CDF of WH . Assuming successful entry into the HP
queue, the PASTA property (e.g., see Tijms [25], Theorem 2.4.1) ensures that our tagged
Poisson-arriving HP patient finds the system in state (i, j) with probability θi,j . Therefore,






θi,j Pr(WH ≤ ω |XL = i,XH = j). (9)
Due to the nature of the preemptive service rule in place, the quantity Pr(WH ≤ ω |XL =
i,XH = j) does not depend upon the number of LP transplant requests present upon




θ•,j Pr(WH ≤ ω |XH = j), (10)
where θ•,j =
∑m
i=0 θi,j denotes the marginal distribution of the HP queue length.
With XH = j, we observe that WH initially consists of the total time required to clear
the j class-1 patients ahead of the newly-arriving HP patient. Since all class-1 patients
ahead of this HP patient might renege (including the one receiving service at rate µ1), the





k , a sum of j+1 independent random variables in which each Y
H
k is exponentially
distributed at rate βk = µ1+kα1. The resulting distribution is a member of the phase-type
family of distributions (e.g., see Latouche and Ramaswami [16], Chapter 2), so that
Pr(WH ≤ ω |XH = j) = 1− ej+1 exp{Tj+1ω}1′j+1, (11)
where Tj+1 is a (j + 1)× (j + 1) matrix of the form
Tj+1 =

−βj βj 0 · · · 0 0
0 −βj−1 βj−1
. . . 0 0
0 0 −βj−2







0 0 0 · · · −β1 β1
0 0 0 · · · 0 −β0

. (12)
Substituting (11) into (10), it is possible to express the distribution of WH in terms of a
single, succinct phase-type representation of dimension n, namely
FH(ω) = 1−Θnexp{Tnω}1′n,
where Θn is the 1× n row vector given by Θn = (θ•,n−1 , θ•,n−2 , . . . , θ•,1 , θ•,0).
We now incorporate the reneging behaviour that our tagged HP patient can exhibit
while residing in the system. LetW ∗H denote the “actual” HP patient delay, representing the
arriving HP patient’s total time spent in system (which incorporates successfully completing
service prior to reneging). For ω ≥ 0, GH(ω) = Pr(W ∗H ≤ ω) = Pr(WH ≤ ω | WH ≤
RH) where RH denotes an exponentially distributed random variable, independent of WH ,
with mean 1/α1. Making use of fundamental matrix algebraic techniques, the following
expressions for GH(ω) and the moments of W
∗
H are ultimately derived:
GH(ω) = 1− Pr(WH > ω |WH ≤ RH)





ω Pr(WH > ω)α1e
−α1xdx−
∫∞












E(W ∗rH ) =
r!Θn
[




, r = 1, 2, . . . . (14)
Note that the denominators of (13) and (14) involve a quantity which we denote by
HPRenege = α1 Θn(α1In−Tn)−11′n, representing the probability our tagged HP patient
abandons the HP queue prior to an organ becoming available to him/her.
5 Delay Distributions for LP Transplant Requests
We next determine stationary delay distributions associated with the arrival of an arbitrary
LP patient to the system. First of all, we focus our attention on a random variable WL,1,
which we define as the duration of time from the arrival of a LP patient to the system
until this patient successfully completes service within the LP queue. Therefore, as in the
definition of WH from the previous section, we refer to WL,1 as the nominal LP patient
delay and likewise assume that there is room in the LP queue for the arriving patient to
enter the system, and that the arriving LP patient is not subject to reneging. (We will
incorporate the reneging behaviour of this patient in our analysis later.)




, i = 0, 1, . . . ,m− 1, j = 0, 1, . . . , n.
We next introduce several row vectors required in the subsequent analysis. First of all,
we define δi to be a 1 × (n + 1) row vector with 1 in position i, i = 1, 2, . . . , n + 1, and
zeros everywhere else. Next, let ϕ
i





, 0, 0, . . . , 0) be the concatenated row vector having a total of
m− i levels. ϕ̃
i
has an overall dimension of (m− i)(n+ 1), i = 0, 1, . . . ,m− 1. If we now
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define Φ = (ϕ̃
m−1, ϕ̃m−2, ϕ̃m−3, . . . , ϕ̃0) to be the concatenated row vector of dimension
ℓ =
∑m−1
i=0 (m− i)(n+ 1) = m(m+ 1)(n+ 1)/2, then by construction Φ1′ℓ = 1.
Upon entry to the system, our tagged Poisson-arriving LP patient must not only wait
for all LP patients in front of it to clear, but for all HP patients, including those present
upon arrival as well as those arriving later to be cleared from the system. (This potentially
includes promoted LP patients who queued behind the tagged LP patient.) As a result,
WL,1 can be modelled as the time to absorption in a Markov chain with infinitesimal





where 0̂r, in general, denotes a 1× r row vector of zeros and the rate matrix R corresponds
to the following state space partitioning:
(i) Level i – the number i of LP patients in front of our tagged LP patient, i =
0, 1, . . . ,m− 1;
(ii) Phase j – the number j of LP patients who queue behind our tagged LP patient,
j = 0, 1, . . . ,m− i− 1;
(iii) Sub-phase k – the number k of HP patients present in the system, k = 0, 1, . . . , n.
Based on the permissible values that i, j, and k can assume, one can readily verify that the
cardinality of this state space equals ℓ, the total number of elements comprising the row
vector Φ.
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In regard to this state space partitioning, the form of the matrix R is given by
R =

m− 1 m− 2 m− 3 · · · 1 0
m− 1 Am−1 Bm−1 0 · · · 0 0
m− 2 0 Am−2 Bm−2
. . . 0 0
m− 3 0 0 Am−3








1 0 0 0 · · · A1 B1
0 0 0 0 · · · 0 A0

. (15)
In (15) above, the diagonal blocks A0,A1, . . . ,Am−1, corresponding to state transitions in
which the number of LP patients in front of our tagged LP patient does not change, are
such that Ai is a square matrix of block dimension m− i in which
Ai =

0 1 2 · · · m−i−2 m−i−1
0 F (i)0 λ2In+1 0 · · · 0 0
1 α2D F (i)1 λ2In+1
. . . 0 0
2 0 2α2D F (i)2








m−i−2 0 0 0 · · · F (i)m−i−2 λ2In+1
m−i−1 0 0 0 · · · (m−i−1)α2D F (i)m−i−1

,
where D, the (n+ 1)× (n+ 1) matrix governing the state transitions in which the number
of queued LP patients behind our tagged LP patient decreases by one, is given by
D =

n n− 1 n− 2 · · · 1 0
n 1 0 0 · · · 0 0
n− 1 p q 0 . . . 0 0








1 0 0 0 · · · q 0




The off-diagonal blocks B1,B2, . . . ,Bm−1 in (15), corresponding to state transitions which
reduce the LP queue in front of our tagged LP patient by one, are such that Bi is a
(m− i)× (m− i+ 1) block matrix given by
Bi =

0 1 2 · · · m−i−1 m−i
0 Ci 0 0 · · · 0 0
1 0 Ci 0
. . . 0 0
2 0 0 Ci








m−i−1 0 0 0 · · · Ci 0

,
where Ci = µ2(δ′n+1 ⊗ δn+1) + iα2D and “⊗” denotes the Kronecker product operator.
Finally, to obtain the diagonal blocks of Ai (i.e., the rate matrices F (i)0 ,F
(i)
1 , . . . ,F
(i)
m−i−1
in which the only state transitions occur within the HP queue) for i = 0, 1, . . . ,m− 1, we
make use of our earlier assumption that the tagged LP patient does not renege, and the
fact that the row sums of P must be equal to 0. This enables us to determine
F (i)m−i−1 =

n n− 1 n− 2 · · · 1 0
n −[βn+(m−1)α2] βn 0 · · · 0 0
n− 1 λ1 −[λ1+βn−1+(m−1)α2] βn−1
. . . 0 0
n− 2 0 λ1 −[λ1+βn−2+(m−1)α2]








1 0 0 0 · · · −[λ1+β1+ (m−1)α2] β1





n n− 1 n− 2 · · · 1 0
n −[λ2+βn+(i+j)α2] βn 0 · · · 0 0
n− 1 λ1 −[λ+βn−1+(i+j)α2] βn−1
. . . 0 0
n− 2 0 λ1 −[λ+βn−2+(i+j)α2]








1 0 0 0 · · · −[λ+β1+(i+j)α2] β1
0 0 0 0 · · · λ1 −(λ+γi+j)

19
for j = 0, 1, . . . ,m− i− 2.
With these pieces in place, the time to absorption in such a Markov chain is once again
phase-type distributed, and so the CDF of WL,1 is given by
FL,1(ω) = 1− Φexp {Rω}1′ℓ .
However, we now incorporate the reneging behaviour of the tagged LP patient by defining
W ∗L,1 to be the actual LP delay (i.e., the arriving LP patient’s total time spent in system
to achieve successful service within the LP queue). Clearly, GL,1(ω) = Pr(W
∗
L,1 ≤ ω) =
Pr(WL,1 ≤ ω|WL,1 ≤ RL) where RL denotes an exponentially distributed random variable,
independent of WL,1, with mean 1/α2. Following the same approach which led to the

















, r = 1, 2, . . . . (17)
We remark that the denominators of (16) and (17) involve the LP reneging probability
LPRenege = α2Φ(α2Iℓ −R)−11′ℓ .
We next turn our attention to characterizing the distribution ofWL,2, which we define as
the nominal delay experienced from the point of transfer to the HP queue of a promoted LP
patient until that patient successfully completes service. We remark that this distribution
will look different than that which is perceived by the externally-arriving class-1 stream,
as the instants at which promotions occur is clearly dependent upon the present length
of the LP queue. However, conditional on encountering j class-1 patients ahead of the
promoted LP patient, the results of the previous section can still be applied to ascertain
that the nominal delay the promoted patient experiences in order to complete service is
phase-type distributed with rate matrix given by (12). The difference will lie in the initial
probability vector to use in connection with this phase-type distribution, as Θn from the
previous section is no longer appropriate.
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As a means of identifying the proper initial probability vector to use, we track the
potential path our tagged LP patient can take with respect to three distinct final outcomes
(or dispositions) within the LP queue. We label these final outcomes as follows:
F1 ≡ tagged LP patient completes successful service in the LP queue,
F2 ≡ tagged LP patient reneges and exits the system from the LP queue, and
F3 ≡ tagged LP patient receives promotion to the HP queue.
The event F3 can be further broken down into elemental final outcomes F3 =
{fn, fn−1, . . . , f0}, where fi represents the outcome in which our tagged LP patient finds i
class-1 patients ahead of it upon promotion. Note that fn represents the outcome that the
HP queue is full at the instant of promotion. As a matter of completeness, we include fn
in the set F3 (although its associated probability will be singled out later on as a blocking
probability of interest). Let ∆F = {F1, F2, fn, fn−1, . . . , f0} be the set of states correspond-
ing to these final outcomes. Also, let ∆L represent the set of states corresponding to our
tagged LP patient residing in the LP queue, having the same state space partitioning as
the rate matrix R above. In order to track which of these final outcomes the tagged LP








where S = R−α2Iℓ. Recall that the matrix R given by (15) did not take into account the
reneging behaviour of our tagged LP patient. However, our current treatment necessitates
the incorporation of this reneging behaviour, and as such, the definition of S includes the
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additional term −α2Iℓ. Furthermore, the block-structured matrix T is given by
T =

F1 F2 fn fn−1 · · · f0
m−1 0̂′n+1 qα21′n+1 pα2(1′1 ⊗ δ′1) pα2(1′1 ⊗ δ′2) · · · pα2(1′1 ⊗ δ′n+1)
m−2 0̂′2(n+1) qα21′2(n+1) pα2(1
′
2 ⊗ δ′1) pα2(1′2 ⊗ δ′2) · · · pα2(1′2 ⊗ δ′n+1)
m−3 0̂′3(n+1) qα21′3(n+1) pα2(1
′














m−1 ⊗ δ′1) pα2(1′m−1 ⊗ δ′2) · · · pα2(1′m−1 ⊗ δ′n+1)
0 µ2(1
′
m ⊗ δ′n+1) qα21′m(n+1) pα2(1
′
m ⊗ δ′1) pα2(1′m ⊗ δ′2) · · · pα2(1′m ⊗ δ′n+1)

.
We wish to determine the absorption probabilities into each of the n + 1 states of F3,
which we denote by ψ(fi), i = 0, 1, . . . , n. This is accomplished by analyzing the embedded
Markov chain (or jump process) associated with the above continuous-time Markov chain.
Specifically, the (one-step) transition probability matrix of the associated jump process is




∆L Iℓ − diag(S)−1S −diag(S)−1T
∆F 0 In+3
, (18)
where diag(S) denotes the matrix containing only diag(S)’s diagonal entries. The funda-












= Φ(α2Iℓ −R)−1T ′n+3−i,
where T ′n+3−i denotes the (n+3−i)th column of T , i = 0, 1, . . . , n. Of particular relevance is
the quantity ψ(fn), which represents the probability that the tagged LP patient encounters
a full HP queue at the instant of its promotion (and is thus denied entry and subsequently
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exits the system). In other words, ψ(fn) is another blocking probability of interest. In
keeping with our earlier choice of notation, we also let PromLPBlock = ψ(fn).
Clearly,
∑n
i=0 ψ(fi) = p · LPRenege, and so the 1× n row vector
Ψn =
1
p · LPRenege− ψ(fn)
(
ψ(fn−1), ψ(fn−2), . . . , ψ(f0)
)
contains the (normalized) probabilities for the number of potential HP patients present in
the HP queue at the instant that the LP patient is successfully promoted to the HP queue.
With this analogue of Θn in hand, we make use of the phase-type distributional results of
the previous section to immediately obtain
FL,2(ω) = Pr(WL,2 ≤ ω) = 1−Ψnexp{Tnω}1′n.
In addition, the associated delay distribution defined by the conditional random variable












, r = 1, 2, . . . ,
where PromLPRenege = α1 Ψn(α1In−Tn)−11′n represents the probability that a self-
promoted LP patient leaves the system prior to an organ becoming available to him/her.
6 Model Calibration Via a Parametric Competing Risks
Framework
Solid organ transplantation wait-list data differs from the usual queueing perspective in
several aspects. A patient’s arrival time, waiting time, and service time are still tracked,
but there are additional complications due to both abandonments (e.g., deaths and coming
off-list) and self-promotion in priority due to health degradation. In this context, the cause
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for a patient to leave the queue needs to be tracked as well as their time in the system;
such data can be modelled using a “competing risks” framework (e.g., see Kalbfleisch and
Prentice [10] or Lawless [17]).
To be specific, we are interested in simultaneously modelling more than one event time
variable. Consider the arrival of a LP patient, who can exit the LP queue either by obtaining
a transplanted organ, or by reneging (i.e., promotion to the HP queue, death, or recovery
to off-list status). If such a patient left the system as a result of obtaining a transplanted
organ, we know not only the exact time of this event, but we also know that their time to
renege would have been longer (i.e., their reneging time is right-censored). Conversely, had
the patient reneged, then their time to transplant would have been right-censored.
We have assumed that external arrivals to both queues follow independent Poisson
processes and that the transplant and reneging times are exponentially distributed. In
this parametric modelling context, it is possible to construct a likelihood function that
incorporates the notion of a competition between the class-specific transplantation and
reneging rates. Given data, the model can then be calibrated by estimating the parameters
using a maximum-likelihood-based approach. The suitability of assuming exponential inter-
availability times was discussed at length in Stanford et al. [21], and that result was
employed in [22] to show why it is reasonable to make that assumption in the presence of
random ABO-compatible transplantation.
Consider the case of two generic competing risks represented by the event time random
variables T1 and T2. When the observed times {ti; i ∈ Z+} can be viewed as independent,












In (19) above, δi is an indicator function taking the value 1 if the i
th event was due to the
type 1 event, and 0 if it was due to the type 2 event, while fTj (·) and FTj (·), j = 1, 2, are
used to denote the respective probability density and cumulative distribution functions for
the two competing event times.
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It is not possible to directly employ the likelihood approach outlined above using T1 as
the system time of a LP patient and T2 as the corresponding time to renege, because the
system times of successive patients are not independent. Rather, they are highly correlated
since successive system times in a heavily-loaded queue will have a great degree of overlap.
Instead, we consider the sequence of observed “inter-exit times” within each priority stream,
which we assume are at least approximately independent.
Calibration of the LP stream using maximum likelihood based on the sequence of ob-
served inter-exit times from the LP queue proceeds as follows. Suppose n2 such exit events
are observed in the LP queue over the duration of the study period, and that these are
indexed by i. Let the random variable Ti denote the i
th inter-exit time, and let ti be its
observed value. Here, Ti = min{T1i, T2i}, where T1i is the random time until the next LP
transplantation and T2i is the random time until the next abandonment. The i
th inter-exit
time then contributes the factor Li from (19) to the likelihood function L, where δi is an
indicator of successful service.
Due to the memoryless property of the exponential distribution, each residual time
to transplant remains exponentially distributed at rate µ2. Each residual time until the
first abandonment from the LP queue is also still exponentially distributed (because it is
the minimum of a finite number of independent exponential random variables), but at an
accelerated rate of α2(t) = N2(t)α2, where N2(t) represents the random number of LP
patients waiting at time t. In this context, the likelihood function for the LP stream is
approximately proportional to












The likelihood function given by (20) is an approximation, because we do not allow for
N2(t) to vary during an inter-exit time due to new arrivals to the LP queue. To further
simplify our estimation scheme, we assume a fixed value for the LP queue size, setting
N2(t) = N2 ∈ Z+. Our rationale for this restriction is that, although there is fluctuation
in the LP queue size, it appeared to remain fairly constant in the liver transplant data we
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consider in the next section.
Given such data, the maximum likelihood estimates (MLEs), obtained by maximizing












We observe that if there were no abandonments and no censoring, the estimated service
rate would be the reciprocal of the average service time, as one would expect from a random
sample of an exponential distribution.
In our framework, the probability p of being promoted to HP status occurs at random.
LP patients who renege are considered to either immediately “self-promote” to the HP
queue with probability p, or to exit the system with probability q = 1 − p, independently
of the others. The total number of reneging LP patients who become promoted is thus
a binomial random variable, whose MLE p̂ is well known to be the empirical proportion
of “successes”. In our context, p̂ is the observed proportion of reneging LP patients who
receive promotion to the HP queue.
The calibration of the HP stream follows by analogy to the LP case described above.
The LP and HP streams are analyzed separately due to the assumption that HP patients
are served on a FCFT basis, regardless as to how they entered that queue. Suppose that
there were n1 customers who entered the HP queue, either directly as a new arrival or
through reneging from the LP queue, and that these observations are indexed by j. The














where δ∗j is an indicator function taking the value 1 if the j
th HP patient successfully
achieved service, {tj ; j ∈ Z+} are the observed inter-exit times in the HP queue, and N1
is the (assumed) number of HP patients present in the queue at any given instant.
Finally, the class-specific arrivals are assumed to follow separate, homogeneous Poisson
processes and we assume patients arrive independently to the queueing system. In this
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context, the MLEs are clearly λ̂1 = n1/S and λ̂2 = n2/S, where S denotes the length of
the study period.
7 Case Study: Analysis of Liver Transplantation Data
In this section, we present an analysis of liver transplantation wait-list data provided by a
regional health centre in Canada, under its Research Ethics Board guidelines for secondary
use of anonymous information. Anonymous parameters were derived from a data set of
nearly 1,100 patients who were on that region’s liver wait list from January 2000 through
December 2012, inclusive. A status and date profile was provided for each patient. This
information tracked changes to each patient’s CanWAIT (Canadian wait-listing algorithm
in transplantation) status for human livers over the duration of their stay on the wait
list. The ordinal set of CanWAIT status codes for a human liver are described in Table 1
(adapted from Bazarah et al. [3], Table 2).
As noted in [3], donor livers are typically allocated and transplanted regionally. How-
ever, patients with a CanWAIT status of 3F, 4, or 4F are considered “high-status patients”,
and are placed on a national wait list. Donor livers are directed to these patients as they
become available from anywhere in the country. We categorized such patients as our HP
patients, while the remaining patients with CanWAIT scores of 1, 1T, 2, or 3 were consid-
ered to be LP patients. Patients with initial scores in this range, whose health subsequently
degraded to a 3F, 4, or 4F status, were considered to be LP patients who self-promoted to
the HP queue. If a patient was placed “on hold” (a CanWAIT score of 0), we assumed their
priority in the queue did not change during the period they were in that status. In addition,
although some short-duration oscillations between the LP and HP states were observed in
the records of some patients, these were ignored and those patients were treated as if they
stayed in the originating priority stream for the entire period in question.
Estimates for each of the model’s parameters were obtained via the methodology out-






1T At home with a liver tumour
2 In hospital in stable condition
3 In intensive or equivalent care facility but not requiring mechanical support,
with either: Creatinine > 200 mmol/L or rising by > 50 mmol/L/day; or,
Grade 3 or 4 encephalopathy
3F In intensive or equivalent care facility for fulminant liver failure but not on
mechanical support, who fulfills the King’s College criteria for high risk of
mortality without liver transplantation
4 In intensive care requiring mechanical ventilation support; without liver
transplantation, death is considered imminent
4F In intensive care requiring mechanical ventilation for fulminant liver fail-
ure, including nonfunction of a primary graft; without liver transplantation,
death is considered imminent
0 On hold
Table 1: Canadian wait-listing algorithm in transplantation (CanWAIT) status codes for
liver transplantation (adapted from Bazarah et al. [3], Table 2).
priority stream at any given instant of time, were obtained by viewing time-series plots of
the moving average of each of the two priority queue sizes. A set of ABO blood-type specific
estimates appears in Table 2. Due to the disparate relative frequencies of blood types in
Canada (e.g., see [5]), no results for blood type AB are presented. There were only about
60 type AB patients and of these, less than a dozen patients entered the HP queue (either
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directly or through self-promotion). Consequently, the corresponding parameter estimates
were deemed not to be reliable. Blood types A and O each had over 400 patients in the
wait-list records and approximately 130 patients had type B blood.
We remark that the LP placement rate for type O of 0.08214 per day is about 10%
higher than type A’s placement rate of 0.07665 per day, which reflects the Canadian blood
mix of 46% type O versus 42% type A quite nicely (e.g., see [5]). In contrast to this, the
type A transplantation rate of 0.05830 per day is itself about 10% higher than the type O
value of 0.05354 per day. In the case of ABO-identical transplantation, we would anticipate
the reverse situation, so this seems to suggest that recipients of type A must be getting a
non-trivial number of type O livers. This is in keeping, qualitatively at least, with what
has been reported in other jurisdictions (e.g., see Glander et al. [7], Liefeldt et al. [18],
and other references listed in Stanford et al. [22]). The estimates also suggest that there
is about one HP placement for every 5 LP placements for blood types O and B, and about
one HP placement for every 6 LP placements for blood type A.
The model was run under three scenarios (i.e., for each of blood types O, A, and B),
corresponding to the sets of parameter estimates given in Table 2. The buffer sizes used
for our model, along with the corresponding set of blocking probabilities obtained, are
displayed in Table 3 for each blood-type specific case. We remark that the chosen values
for m and n yield negligible blocking probabilities in all cases.
Figures 2 through 4 display the estimated cumulative distribution functions of the
system times for three different categories of successfully-transplanted patients. Each figure
presents model-based and empirically-estimated results for the three blood-type specific
models. We note that Figures 2 and 3 are measured in days, while Figure 4 is measured
in months, reflecting the fact that LP patients who ultimately get transplanted in the LP
queue wait much longer than individuals who are transplanted as HP patients.
Figures 2 and 3 compare the empirical waiting times of HP patients with the results of
our model for patients who arrived directly to the HP queue and for LP arrivals that sub-
sequently self-promoted to the HP queue, respectively. For LP arrivals that subsequently
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Parameter Type O Type A Type B
λ1 0.01605 0.01225 0.00465
λ2 0.08214 0.07665 0.02196
µ1 0.11888 0.37037 0.20968
µ2 0.05354 0.05830 0.01449
α1 0.05828 0.05926 0.14516
α2 0.00096 0.00148 0.00120
p 0.23810 0.20430 0.23404
N1 1 1 1
N2 31 13 9
Table 2: Blood-type specific parameter estimates for the study data. (* Note that the
blood type AB results are not presented due to small-sample effects, as this blood type is
rare in Canada.)
Quantity Type O Type A Type B
m 65 40 20
n 3 3 3
LPBlock 0.000735 0.000171 0.001226
HPBlock 0.001064 0.000039 0.000003
PromLPBlock 0.000116 0.000003 0.000000
Table 3: Blood-type specific buffer sizes used and blocking probabilities obtained for the
study data.
self-promoted to the HP queue, the “system time” we display starts at the moment of
promotion. Typically, the percentiles estimated from the models are similar to the corre-
sponding empirical percentiles. The empirical results for blood type B are more variable,
which is not suprising as this blood type is less common. Less than a dozen patients with
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type B blood self-promoted from LP to HP, which explains why the bottom panel of Figure
3 is not as smooth as the empirical cumulative distribution functions for types O and A.
Whereas our HP results might be described as adequate, the same could not be said for
the LP queue. In contrast to the consistency of the HP results, Figure 4 reveals that the
LP system time forecast by the model can be overly conservative for short delays, and can
fail to capture the extreme tail of the empirical waiting time distribution. Upon reflection
and further analysis of the source data records, it appears that the empirical behaviour
is consistent with the operation of a wait list involving three priority levels. Specifically,
patient codes 0 through 3 are being further pooled into two distinct priority classes, and
not a single class as we have considered here. This possibility calls for investigation of
other centres, to see whether what we have observed at the health centre under study is
common there as well. In parallel, it suggests that a three-class analogue of the model
being presented here should be pursued, even if the present model may indeed prove to be
adequate at a wide range of health centres.
We remark that the existence of a multi-level clinical distinction of patient acuity such as
CanWAIT rarely translates operationally class for class, in the second author’s experience,
to a multi-priority queue. Typically, there are either two priority classes, or three priority
classes as we have observed at play here. An iterative model building approach, aided by
expert perception of what is occurring, medically and mathematically, is therefore needed
to determine the number of priority classes in operation.
Table 4 compares the model-based reneging rates for each of the three separate models
to the corresponding empirically-observed rates. The overall reneging rate from the LP
queue as well as the abandonment rate of LP patients from the entire system are given.
Separate reneging rates for the two types of HP patients, namely those who directly arrived
to the HP queue and those who arrived as a LP patient and subsequently self-promoted
to the HP queue, are also given. In general, the model-based reneging rates exceed those
observed in the data for blood type O. A similar pattern is also seen for the blood type A
results, although the model and empirical-based estimates are in relatively close agreement.
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Blood Type & Rate Estimate Overall LP LP Abandon Only HP Promoted LP
Type O (model) 0.4348 0.3313 0.3522 0.3527
Type O (empirical) 0.3779 0.2879 0.3289 0.3429
Type A (model) 0.2749 0.2187 0.1420 0.1423
Type A (empirical) 0.2562 0.2039 0.1379 0.1579
Type B (model) 0.3730 0.2857 0.4123 0.4125
Type B (empirical) 0.4519 0.3462 0.4091 0.4545
Table 4: Model-based and empirical-based estimates of reneging rates, stratified by the
blood type of the patient. Overall LP is the overall reneging rate from the LP queue, while
LP Abandon Only is the abandonment rate. HP is the reneging rate of HP patients who
arrived directly to that priority stream, while Promoted LP is the reneging rate of HP
patients who arrived as LP patients and subsequently self-promoted to the HP queue.
For the type B model, the opposite is observed and there is close agreement for the reneging
rates of patients who entered directly as HP.
Table 5 presents model-based and sample-based estimates for the mean system times,
as well as the corresponding estimated standard deviations, for the different categories of
patients who were successfully transplanted. The model means for direct-entry HP patients
and self-promoted LP patients are similar for type O patients and so are the corresponding
standard deviations. The empirical means for successful HP patients – regardless as to how
they entered that stream – are about twice as large than what is estimated by the model
for type A and type B patients and the corresponding empirical standard deviations are
also larger than those based on the fitted models. Conversely, the model-based estimated
mean system time for successful LP patients is much larger than the HP means, regardless
of blood type. For type A and type B patients, the empirical mean time to transplant for
LP patients is larger than the model means. The empirical standard deviations for the
mean time to transplantation as a LP patient are also quite large, reflecting the fact that
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Model Mean Empirical Mean Model SD Empirical SD
Type O Model
Successful direct-entry HP 6.1 6.2 6.0 5.7
Successful self-promoted LP 6.1 6.1 6.0 6.4
Successful LP 581.5 474.9 156.5 532.5
Type A Model
Successful direct-entry HP 2.4 4.8 2.4 4.1
Successful self-promoted LP 2.4 5.2 2.4 4.6
Successful LP 209.2 306.5 104.0 304.3
Type B Model
Successful direct-entry HP 2.8 4.5 2.8 4.1
Successful self-promoted LP 2.8 5.7 2.8 5.8
Successful LP 360.2 528.7 211.7 508.2
Table 5: Model-based and empirical-based estimates of the mean system times (measured
in days) for patients who were successfully transplanted, along with their corresponding
standard deviations (SDs). Results are given for each of the blood-type specific models.
The system times for three different types of patients are considered: direct-entry HP
patients, self-promoted LP patients, and LP patients who never left the LP queue.
there are some patients who appear to spend a very long time in the LP queue, without
abandoning that queue or self-promoting to the HP queue due to health degradation, who
eventually get successfully transplanted.
Overall, these results seem to suggest that our model of LP system time fails to capture
the high observed variability in waiting times, and the HP models are generally overly
conservative. Future work will need to pursue all of the following avenues: revisiting the
model assumptions regarding placement and abandonment rates, refining the parameter
estimates, and testing the model against observed data from other wait lists. Nonetheless,
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we remark that a queueing model would still be a useful decision-making tool if it could be
used qualitatively to explore the impact of various policy changes. Its use is not primarily
a matter of forecasting the likelihood of delays as experienced by individual patients placed
on the wait list.
8 Concluding Remarks
We have presented a model for estimating patient waiting times in deceased-donor trans-
plant queues, which reflects both the propensity for patients to renege from the queue,
and to self-promote to urgent status. Performance measures of interest we obtain include
the waiting time distributions and their moments, the queue length distributions, and the
reneging probabilities. These results are obtained for patients who are urgent when placed
on the wait list, for those who have a regular status and receive their organ in regular status,
and for those regular status placements who become urgent prior to transplantation.
In addition to the probabilistic results, which take the form of matrix geometric solutions
for the queue lengths and phase-type distributions for the waiting times, we also have
presented a maximum-likelihood-based procedure for estimation of the model parameters.
These results were then applied to study a single liver transplantation centre in Ontario.
Whereas the fit of waiting time for patients transplanted with an urgent status appeared
to be appropriate, the fit for the regular stream of patients was deemed inadequate, since
it appeared that the wait list comprised three priority classes operationally. Future work
will proceed along two directions. On the one hand, we hope to be able to apply the data
to other transplantation centres, to see if our two-class priority model is appropriate. On
the other, we plan to extend the existing results to allow for a third priority class. The
approach would parallel the methodology used in the two-class case.
We remind readers that some of the estimates in the previous section were based on the
analysis of relatively small samples of data, in particular for the case of blood type B in the
overall population. Furthermore, we felt that our estimates of AB data were too imprecise
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to be reliable, as they were based on too few data values. More precise estimates could be
obtained through an analysis of longer records or through analysis of data from multiple
health centres over the same study period.
Our model’s assumption that all blood types have the same propensity to renege per
unit time waiting is consistent with the medical view that blood type does not influence
health degradation. Nonetheless, the longer a patient waits, the greater the chance for
that patient to experience degraded health. The results obtained from our model suggest
a substantial discrepancy in the HP reneging rate for blood type B than for blood types
O and A; however, once again one needs to view this in the context of small numbers of
urgent patients of all blood types. It would seem that further work to statistically estimate
the abandonment parameters is called for.
Finally, it is clear that donor allocation in transplantation is a complex system depend-
ing on several interacting clinical and administrative events. We believe we have shown
that this system is, despite its complexity, amenable to logical analysis using standard
queueing theory. Further work is needed in terms of adequate parameter estimation, and
other possible refinements to the modelling assumptions noted above may be needed after
further numerical investigations.
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Figure 2: Model-based (solid red lines) and empirical-based (dashed black lines) estimates
for the cumulative distribution functions of the system time of a successfully-transplanted
HP patient who entered the system originally as an HP patient. Results for each of the
blood-type specific models appear in separate panels.
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Figure 3: Model-based (solid red lines) and empirical-based (dashed black lines) estimates
for the cumulative distribution functions of the system time of a successfully-transplanted
HP patient who originally arrived as a LP patient and subsequently self-promoted to the
HP queue. Here, system time is measured from the time of promotion to the HP queue.
Results for each of the blood-type specific models appear in separate panels.
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Figure 4: Model-based (solid red lines) and empirical-based (dashed black lines) estimates
for the cumulative distribution functions of the system time of a LP patient who was
successfully transplanted within the LP queue. Results for each of the blood-type specific
models appear in separate panels.
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